A few years ago, we developed metaan, a package to perform fixedor random-effects meta-analysis. In terms of random-effects meta-analysis, it offered a wide choice of models, including maximum likelihood, profile likelihood, or restricted maximum-likelihood, in addition to the established DerSimonian–Laird method available in metan or Cochrane’s RevMan software. Other unique features included a wide range of reported heterogeneity measures and a plot of the maximum likelihood function. Since then, metaan has been continuously updated to offer improved graphics, more options, and more meta-analysis models. In this necessary update, we describe these additions and discuss the new models and the evidence behind them.
No takes yet. Share an insight, caveat, or question.
Kontopantelis et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: